Driving Factors of Decision Making for Prophylactic Salpingectomy Versus Tubal Ligation at the Time of Cesarean Section

April 29, 2020 updated by: Murat Yassa, Bartin State Hospital

Prophylactic (Opportunistic) salpingectomy is a cost-effective strategy recommended for reducing the risk of ovarian cancer at the time of gynecologic surgery in women who have completed childbearing. Similar evidence for cesarean section is growing. However, salpingectomy refers to the surgical removal of a female reproductive organ. Some women may have hesitations about salpingectomy with regard to religious concerns, reduced self-image, tubal reanastomosis or lack of knowledge.

The investigators aimed to explore the underlying factors that motivate women for either decisions.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Prophylactic and opportunistic bilateral salpingectomy is an increasing trend among surgeons and also proven as an effective risk-reducing method for ovarian cancer.

The investigators have experienced denials among women who were seeking tubal ligation as a sterilization procedure during cesarean section after a comprehensive counseling for prophylactic salpingectomy. Therefore, the investigators aimed to assess the driving factors of decision making for prophylactic salpingectomy or tubal ligation. It is planned to preoperatively have a non-validated questionnaire for the women after a detailed briefing.

Study Type

Observational

Enrollment (Actual)

58

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bartin, Turkey
        • Bartin State Hospital
      • Istanbul, Turkey
        • Istanbul Sisli Hamidiye Etfal Training And Research Hospital, Health Sciences University
      • Istanbul, Turkey
        • Medicalpark Gaziosmanpasa Hospital, Istinye University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Women who aged over 18 years old and seek for sterilization at the time of cesarean section.

Description

Inclusion Criteria:

  • Women seeking for surgical sterilization during their cesarean section
  • Elective and Category 2 or more planned cesarean sections

Exclusion Criteria:

  • Clinical conditions that lead to planned cesarean hysterectomy such as placenta percreata
  • History of ovarian cancer, previous chemotherapy or radiation
  • Women who previously underwent sterilization

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Salpingectomy
Women who gave consent for opportunistic prophylactic bilateral salpingectomy during cesarean section as a Surgical sterilization procedure
Surgical sterilization either standard salpingectomy or tubal ligation with Pomeroy technique
Tubal ligation
Women who refused salpingectomy and gave consent for tubal ligation during cesarean section as a Surgical sterilization procedure
Surgical sterilization either standard salpingectomy or tubal ligation with Pomeroy technique

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Motivators for sterilization type
Time Frame: Evaluation at preoperative 32th gestational weeks
A non-validated data collection tool with open-ended questions assessing the factors behind the decision of salpingectomy or tubal ligation. Data collection tool questions why patients choosed or refused salpingectomy in detail. It is not a scale and does not have a range.
Evaluation at preoperative 32th gestational weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Murat Yassa, M.D., specialist

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

February 10, 2019

Primary Completion (ACTUAL)

December 10, 2019

Study Completion (ACTUAL)

February 1, 2020

Study Registration Dates

First Submitted

February 3, 2019

First Submitted That Met QC Criteria

February 4, 2019

First Posted (ACTUAL)

February 5, 2019

Study Record Updates

Last Update Posted (ACTUAL)

April 30, 2020

Last Update Submitted That Met QC Criteria

April 29, 2020

Last Verified

April 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • EtfalSalp

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sterilization, Tubal

Clinical Trials on Surgical sterilization

3
Subscribe